C-type natriuretic peptide in vascular physiology and disease.
about
Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritisAdvances in research on and diagnosis and treatment of achondroplasia in China.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery.Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.In vitro evaluation of cenderitide-eluting stent I -an antirestenosis and proendothelization approach.In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.Associations Between Genetic Variants of the Natriuretic Peptide System and Blood Pressure Response to Dietary Sodium Intervention: The GenSalt Study.Serial Evaluation of Abdominal Fluid and Serum Amino-terminal pro-C-type Natriuretic Peptide in Dogs with Septic PeritonitisNatriuretic peptide C receptor signalling in the heart and vasculature.Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.Myocardium tissue changes caused by electrical transthoracic discharges in rats.Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug.Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertensionNatriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis.Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.Statins exert endothelial atheroprotective effects via the KLF2 transcription factor.B-type natriuretic peptide decreases gastric emptying and absorption.C-type natriuretic peptide attenuates LPS-induced endothelial activation: involvement of p38, Akt, and NF-κB pathways.Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.Functional characteristics of mesenchymal stem cells derived from the adipose tissue of a patient with achondroplasia.Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease.Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.A Micro-Scale Model to Monitor the Major Proteins in Human Urine Before and After Medication with Angiotensin-Converting Enzyme Inhibitor: A Preliminary StudyC-Type Natriuretic Peptide (CNP) Inhibition of Interferon-γ-Mediated Gene Expression in Human Endothelial Cells In Vitro
P2860
Q33667772-9B3A6D88-6FDB-405D-B5F1-0368A617C788Q34377947-E75E3C3B-B97A-436F-9BE1-508824322512Q34979675-697F1340-3BA2-409D-B7FA-193F988B3D7CQ35566943-94C0B0C1-1E60-4BD3-8DB1-8533544FEF51Q36054413-3D1AE680-491A-4F88-BF25-7B5292F4377FQ36144664-ED7C4F5D-4D56-4ED1-A0DA-28A38BB58F2EQ36206241-3A9EF0CF-A8D0-491F-ABA3-4F19D0F72EF8Q36470750-0B7FF847-BEF5-43B0-B392-1F89392544D9Q36591776-01C8B53E-1E53-4DAE-8852-959B7244F993Q36873538-220A0A3D-7028-43B8-8604-CBF9BA7BAC12Q37002318-BD6ECE06-FE9E-421C-93C9-4962831E3856Q37071264-03296C4D-F908-4BEC-B471-6F0ECC4C5329Q37157505-16DA5848-34EA-4697-ADFC-019FA9D6A8A8Q37406870-C19B6985-45DD-4AED-866E-DB24738B66F1Q38316458-DBBD057D-17F1-4C21-AD87-F39775D45404Q38847918-4A319BF9-2CDA-4B83-8A3B-2FA13F2633CFQ40355020-59E7AC5F-D023-4A1B-BBB1-4CAFF1E1A415Q40649909-32BB7938-AED4-41BE-A0ED-D4439BC25D26Q41672035-2893E24D-4311-48CE-A54A-D0F4D8B79510Q42822789-03459A1A-3974-4B33-AC92-D107263D8DA8Q44710575-7980DC85-8E4B-4963-91F9-56BEFF8EA419Q46477118-1604AF75-A1D0-4448-A12E-62AC14CB58EFQ46681492-D7B0A250-7B3B-4988-A3A5-9C898A8F9D8FQ46856213-25655651-E747-4D42-AF2F-00D5EBF2124EQ48156451-5A70DDBE-DD49-4145-A2ED-D4102B914E0FQ53126707-20EF29B3-E194-496C-B96D-6BFA6E97F4FFQ54969950-D8180D90-2389-46D2-AF90-78162DF9395CQ55381492-E4B2C50B-9CBD-4FD8-9416-E739EC67DAEDQ58309332-95A16C90-96CA-496E-88E3-1D4B65642A41Q58738761-297EF4E1-7174-4F75-8D2A-E68D74FFC0F0
P2860
C-type natriuretic peptide in vascular physiology and disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
C-type natriuretic peptide in vascular physiology and disease.
@ast
C-type natriuretic peptide in vascular physiology and disease.
@en
type
label
C-type natriuretic peptide in vascular physiology and disease.
@ast
C-type natriuretic peptide in vascular physiology and disease.
@en
prefLabel
C-type natriuretic peptide in vascular physiology and disease.
@ast
C-type natriuretic peptide in vascular physiology and disease.
@en
P1476
C-type natriuretic peptide in vascular physiology and disease
@en
P2093
Ramona S Scotland
P356
10.1016/J.PHARMTHERA.2004.08.011
P577
2005-02-01T00:00:00Z